scholarly journals Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach

2013 ◽  
Vol 199 (9) ◽  
pp. 614-617 ◽  
Author(s):  
Julia M L Brotherton ◽  
Sharron L Murray ◽  
Madeline A Hall ◽  
Lynne K Andrewartha ◽  
Carolyn A Banks ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Vaccine Coverage ◽  
Human Papillomavirus Vaccine ◽  
School Based ◽  
Papillomavirus Vaccine

scholarly journals Print News Coverage of School-Based Human Papillomavirus Vaccine Mandates

2014 ◽  
Vol 84 (2) ◽  
pp. 71-81 ◽  
Author(s):  
Dana M. Casciotti ◽  
Katherine C. Smith ◽  
Lindsay Andon ◽  
Jon Vernick ◽  
Amy Tsui ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
News Coverage ◽  
Human Papillomavirus Vaccine ◽  
Print News ◽  
School Based ◽  
Vaccine Mandates ◽  
Papillomavirus Vaccine

Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon

2011 ◽  
Vol 52 (6) ◽  
pp. 456-458 ◽  
Author(s):  
Rachel Gold ◽  
Allison L. Naleway ◽  
Loretta L. Jenkins ◽  
Karen K. Riedlinger ◽  
Samantha K. Kurosky ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Health Centers ◽  
Human Papillomavirus Vaccine ◽  
School Based ◽  
School Based Health Centers ◽  
Papillomavirus Vaccine

scholarly journals Human Papillomavirus Vaccine Coverage Among Females Aged 11 to 17 in Texas Counties: An Application of Multilevel, Small Area Estimation

2013 ◽  
Vol 23 (2) ◽  
pp. e131-e141 ◽  
Author(s):  
Jan M. Eberth ◽  
Md Monir Hossain ◽  
Jasmin A. Tiro ◽  
Xingyou Zhang ◽  
James B. Holt ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Small Area ◽  
Vaccine Coverage ◽  
Small Area Estimation ◽  
Human Papillomavirus Vaccine ◽  
Area Estimation ◽  
Papillomavirus Vaccine

scholarly journals Adverse events following school-based vaccination of girls with quadrivalent human papillomavirus vaccine in Slovenia, 2009 to 2013

2016 ◽  
Vol 21 (14) ◽  
Author(s):  
Maja Šubelj ◽  
Veronika Učakar ◽  
Alenka Kraigher ◽  
Irena Klavs
Keyword(s):  
Human Papillomavirus ◽  
Adverse Events ◽  
Vaccination Programme ◽  
Hpv Vaccination ◽  
Monitoring And Evaluation ◽  
Human Papillomavirus Vaccine ◽  
School Based ◽  
Annual Reporting ◽  
Reporting Rates ◽  
Papillomavirus Vaccine

Adverse events following immunisation (AEFIs) with qHPV reported to the Slovenian AEFI Registry for the first four school years of the vaccination programme were analysed. We calculated annual reporting rates for 11–14 year-old vaccinees with AEFIs, using the number of qHPV doses distributed within the school-based vaccination programme as the denominator. Between September 2009 and August 2013, 211 AEFIs that occurred in 89 vaccinees were reported, a rate of 149.5 vaccinees with AEFI per 100,000 qHPV doses distributed. For five vaccinees, serious AEFIs (8.4 per 100,000 doses distributed) were reported. The highest reporting rates were for fatigue, headache, and fever (≥ 38.0⁰) (53.8, 40.3, and 35.3 per 100,000 qHPV doses distributed, respectively). As no AEFI resulted in permanent sequelae and they all were categorised as serious only due to the criterion of a minimum of one day of hospitalisation, this provides reassurance for the safety of our school-based HPV vaccination programme. Further AEFI surveillance is warranted to provide data for HPV vaccination programme monitoring and evaluation of its safety.

Sign in / Sign up

Export Citation Format

Share Document